Your browser doesn't support javascript.
loading
Noncardiac Pulmonary Edema induced by Sitagliptin Treatment.
Belice, Tahir; Yuce, Suleyman; Kizilkaya, Bayram; Kurt, Aysel; Cure, Erkan.
  • Belice T; Department of Internal Medicine, School of Medicine, Recep Tayyip Erdogan University, Islampasa Mahallesi, Rize, Turkey.
  • Yuce S; Department of Internal Medicine, School of Medicine, Recep Tayyip Erdogan University, Islampasa Mahallesi, Rize, Turkey.
  • Kizilkaya B; Department of Internal Medicine, School of Medicine, Recep Tayyip Erdogan University, Islampasa Mahallesi, Rize, Turkey.
  • Kurt A; Department of Thoracic Surgery, Recep Tayyip Erdogan University, Islampasa Mahallesi, Rize, Turkey.
  • Cure E; Department of Internal Medicine, School of Medicine, Recep Tayyip Erdogan University, Islampasa Mahallesi, Rize, Turkey.
J Family Med Prim Care ; 3(4): 456-7, 2014.
Article en En | MEDLINE | ID: mdl-25657966
ABSTRACT
A 74-year-old male patient with type 2 diabetes mellitus admitted to the emergency department with the complaints of progressive breathlessness, dry cough, and swollen lower extremities. Our patient had type 2 diabetes mellitus and hypertension for 3 years. His HbA1c was not within the target range so sitagliptin was added to on-going therapy. After 1 week of starting sitagliptin therapy, even though the patient had not heart failure he applied to the emergency department with a complaint of dyspnea. The cardiovascular safety and efficacy of many anti-hyperglycemic agents such as sitagliptin, saxagliptin are unclear. Our case has shown that dipeptidyl peptidase 4 inhibitors may cause pulmonary edema. Hence, it should be used with cautious, especially in patients with heart failure.
Palabras clave